Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.

Clinical trial NCT00858208 · COMPLETED

Trial details

NCT number: NCT00858208
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Neovascular Age-related Macular Degeneration

Start date: 2008-03-01
Primary completion: 2011-04-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.